The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
IL-23/Th17 axis
arterial stiffness
atherosclerosis
biologics
cardiovascular
psoriasis
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
23 Jan 2023
23 Jan 2023
Historique:
received:
28
12
2022
revised:
16
01
2023
accepted:
22
01
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Accumulating evidence considers psoriasis a systemic inflammatory disorder that is associated with comorbidities such as psoriatic arthritis, cardiovascular disease, and metabolic syndrome. Although the precise pathogenetic links between psoriasis and atherosclerosis warrants further investigation, it is believed that chronic systemic inflammation along with the T helper (Th)-1 and Th17 polarization are associated with endothelial dysfunction and subsequent acceleration of atherosclerosis. Considering the above, several studies have evaluated if optimal control of the inflammation in psoriasis by inhibiting interleukins targeting the Interleukin (IL)-23/Th17 axis could subsequently reduce the atherosclerotic process during anti-psoriatic treatment by using a variety of surrogate markers of subclinical atherosclerosis. This systematic review summarizes current knowledge on the pathogenetic mechanisms and diagnostic evaluation of atherosclerosis in the context of psoriasis and provides a systematic review of the literature on the impact of treatment with biologics targeting the IL-23/Th17 axis on subclinical atherosclerosis in patients with plaque psoriasis and/or psoriatic arthritis.
Identifiants
pubmed: 36830855
pii: biomedicines11020318
doi: 10.3390/biomedicines11020318
pmc: PMC9953668
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Exp Dermatol. 2010 Aug;19(8):736-41
pubmed: 20482619
Br J Dermatol. 2013 Nov;169(5):1081-6
pubmed: 23909282
J Am Acad Dermatol. 2018 Aug;79(2):345-352
pubmed: 29477740
Dermatology. 2019;235(6):478-487
pubmed: 31480039
Sci Rep. 2021 Nov 2;11(1):21438
pubmed: 34728734
J Cutan Med Surg. 2020 Mar/Apr;24(2):209-210
pubmed: 32208025
Clin Exp Dermatol. 2020 Jul;45(5):560-564
pubmed: 31961453
Cureus. 2020 Oct 26;12(10):e11173
pubmed: 33262910
J Eur Acad Dermatol Venereol. 2020 Mar;34(3):533-541
pubmed: 31599476
Int J Mol Sci. 2022 Jan 05;23(1):
pubmed: 35008981
JAMA Dermatol. 2016 Oct 1;152(10):1114-1121
pubmed: 27385305
Int J Dermatol. 2017 Mar;56(3):260-268
pubmed: 27696392
Physiol Res. 2021 Jul 12;70(3):383-391
pubmed: 33982577
Dermatol Ther. 2020 Nov;33(6):e13898
pubmed: 32588950
Front Immunol. 2020 Jan 15;10:3096
pubmed: 32010143
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317
pubmed: 33547728
JAMA Dermatol. 2020 Nov 1;156(11):1208-1215
pubmed: 32902568
JAMA. 2011 Aug 24;306(8):864-71
pubmed: 21862748
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):83-90
pubmed: 23204039
Br J Dermatol. 2018 Aug;179(2):273-281
pubmed: 29432655
Circulation. 2006 Apr 18;113(15):1888-904
pubmed: 16618833
Arthritis Rheumatol. 2018 Mar;70(3):408-416
pubmed: 29088580
Can J Cardiol. 2020 Jan;36(1):100-111
pubmed: 31606265
Exp Dermatol. 2022 May;31(5):781-788
pubmed: 34995387
Cardiovasc Res. 2019 Mar 15;115(4):721-728
pubmed: 30721933
Dermatology. 2009;218(2):110-3
pubmed: 19060461
Int J Med Sci. 2010 Aug 19;7(5):284-9
pubmed: 20827428
Ther Adv Chronic Dis. 2020 Aug 03;11:2040622320944777
pubmed: 32821362
Vasc Health Risk Manag. 2010 Aug 09;6:579-91
pubmed: 20730074
J Dermatolog Treat. 2022 Aug;33(5):2560-2564
pubmed: 35098859
JAMA Cardiol. 2019 Sep 1;4(9):885-891
pubmed: 31365032
Dermatol Ther. 2020 Jul;33(4):e13628
pubmed: 32431027
JAMA Dermatol. 2020 Feb 1;156(2):151-157
pubmed: 31746956
Korean J Fam Med. 2021 Sep;42(5):345-355
pubmed: 32512983
Front Immunol. 2022 Apr 11;13:888763
pubmed: 35479069
Curr Opin Pharmacol. 2022 Dec;67:102292
pubmed: 36228472
Am J Clin Dermatol. 2014 Apr;15(2):137-42
pubmed: 24696418
Medicine (Baltimore). 2016 May;95(20):e3576
pubmed: 27196459
Exp Dermatol. 2011 Apr;20(4):303-7
pubmed: 21410760
Sci Transl Med. 2013 Jul 31;5(196):196ra100
pubmed: 23903754
Arch Neurol. 1982 Nov;39(11):692-5
pubmed: 6181767
J Invest Dermatol. 2017 Aug;137(8):1638-1645
pubmed: 28286061
Atherosclerosis. 2016 Aug;251:25-30
pubmed: 27236353
Int J Mol Sci. 2021 Aug 23;22(16):
pubmed: 34445769
FASEB J. 2014 Jul;28(7):2775-89
pubmed: 24668754
Front Pharmacol. 2020 Feb 25;11:117
pubmed: 32161545
J Dermatolog Treat. 2022 Sep;33(6):2813-2820
pubmed: 35603992
Int J Cardiol. 2011 Sep 15;151(3):382-3
pubmed: 21764467
Dermatol Ther (Heidelb). 2021 Oct;11(5):1497-1520
pubmed: 34505985
Arthritis Rheum. 2007 Mar 15;57(2):287-93
pubmed: 17330278
Circ Cardiovasc Imaging. 2020 Sep;13(9):e011199
pubmed: 32927971
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Br J Dermatol. 2013 Jul;169(1):68-75
pubmed: 23448140
Br J Dermatol. 2013 Nov;169(5):1066-70
pubmed: 23889284
J Eur Acad Dermatol Venereol. 2015 May;29(5):1010-4
pubmed: 24735175
J Dermatolog Treat. 2022 May;33(3):1727-1732
pubmed: 33704001
J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1492-1498
pubmed: 29405437
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394
pubmed: 29776990
Dermatol Ther. 2022 Jul;35(7):e15524
pubmed: 35439341
Dermatol Ther. 2022 Jan;35(1):e15214
pubmed: 34800070
Clin Exp Dermatol. 2018 Apr;43(3):262-267
pubmed: 29333662
Exp Dermatol. 2022 Feb;31(2):237-241
pubmed: 34432926
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1695-1706
pubmed: 32022950
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2488-2495
pubmed: 31385013
Int J Dermatol. 2014 Apr;53(4):503-9
pubmed: 24673360
Arch Immunol Ther Exp (Warsz). 2017 Dec;65(6):463-475
pubmed: 28361180
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
J Invest Dermatol. 2021 Oct;141(10):2402-2411
pubmed: 33891953
Eur Heart J. 2013 Feb;34(8):570-7
pubmed: 22956509
J Immunol. 2010 Nov 15;185(10):5820-7
pubmed: 20952673
Exp Dermatol. 2014 Oct;23(10):701-4
pubmed: 24980461
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1186-91
pubmed: 23981008
J Invest Dermatol. 2020 Sep;140(9):1784-1793.e2
pubmed: 32088207
Front Immunol. 2022 Apr 13;13:835671
pubmed: 35514987
Life (Basel). 2021 Sep 05;11(9):
pubmed: 34575068
Int J Dermatol. 2015 Jul;54(7):839-45
pubmed: 25877149
Int J Mol Sci. 2020 Mar 01;21(5):
pubmed: 32121574
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1531-6
pubmed: 27393182
Circ Res. 2016 Nov 11;119(11):1242-1253
pubmed: 27654120
Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
pubmed: 20339920
J Invest Dermatol. 2019 May;139(5):1054-1062
pubmed: 30508547
J Exp Pharmacol. 2021 Jul 26;13:725-737
pubmed: 34345187
Mol Cell Biochem. 2015 Feb;400(1-2):207-12
pubmed: 25421412
J Eur Acad Dermatol Venereol. 2012 Mar;26 Suppl 2:3-11
pubmed: 22356630
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2461-2498
pubmed: 33349983
J Dermatol. 2016 Nov;43(11):1267-1272
pubmed: 27062420
J Am Acad Dermatol. 2013 Oct;69(4):523-9
pubmed: 23891393
J Eur Acad Dermatol Venereol. 2009 Jan;23(1):1-6
pubmed: 18702627
JAMA Cardiol. 2017 Sep 1;2(9):1013-1018
pubmed: 28564678
Int J Dermatol. 2016 Jan;55(1):52-9
pubmed: 26135969
Br J Clin Pharmacol. 2020 May;86(5):837-851
pubmed: 31957052
J Invest Dermatol. 2017 Aug;137(8):1612-1613
pubmed: 28735613